Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours.

@article{Cardona2003EvaluationOF,
  title={Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours.},
  author={Servando Cardona and Matthias H. M. Schwarzbach and U. G. Hinz and Antonia Dimitrakopoulou-Strauss and Nicolas Attigah and G Mechtersheimer section sign and Thomas Lehnert},
  journal={European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology},
  year={2003},
  volume={29 6},
  pages={536-41}
}
AIMS Benign neurofibromas and malignant peripheral nerve sheath tumours (MPNST) commonly develop in patients with neurofibromatosis. Differentiation of benign from malignant tumours by conventional preoperative imaging is unreliable. FDG-PET is a non-invasive technique for biological tumour evaluation. The aim of this study was to assess the value of FDG-PET in patients with neurogenic tumours suspicious for MPNST. METHODS Benign and malignant neurogenic soft tissue tumours were prospectively… CONTINUE READING
33 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

Similar Papers

Loading similar papers…